Skip to content

    Sudarshan Chemical Industries Q1 FY27 earnings call

    SUDARSCHEM
    Chemicals·14 Aug 2026
    Management Summary

    Sudarshan Chemical Industries Limited delivered a robust Q1 FY27, reporting strong revenue and over 60% YoY EBITDA growth, alongside significant debt reduction. The company is actively integrating its acquired business and driving value capture initiatives. However, geopolitical headwinds, including the Middle East crisis, have led to cost pressures and customer caution, impacting the RIECO segment. Management maintains FY27 guidance but will revisit it after Q2, pending further clarity on market conditions and the financial impact of an employee restructuring program.

    Highlights

    5

    • Strong Q1 FY27 performance with revenue from operations of Rs.2642 Crores and reported EBITDA of Rs.266 Crores, marking over 60% year-on-year growth.

    • Significant debt reduction, bringing net debt down by 60% from its peak of Rs.922 Crores to Rs.531 Crores, resulting in a healthy debt-to-equity ratio of 0.2.

    • Return on capital employed is robust at 22.7%, indicating efficient capital utilization.

    • Management expects gross profit margins to sustain in the 50% plus range, driven by ongoing cost reduction and value capture initiatives.

    • Successful integration of the acquired business, with a focus on recapturing lost sales and improving EBITDA margins through lean operations.

    Concerns

    4

    • The Middle East crisis has led to energy cost spikes, increased raw material costs, and logistic cycle delays by two weeks, impacting operations.

    • Customer purchasing behavior is cautious, with many delaying orders to avoid stock buildup due to geopolitical uncertainties.

    • The RIECO business experienced a challenging quarter with revenue at Rs.38 Crores and an EBITDA drop, primarily due to delays in customer readiness and subcontracting manpower availability.

    • An employee restructuring program has been signed, but its financial impact is not yet quantified, with clarity expected by Q2 FY27.

    Key financials

    Single quarter

    08 metrics
    1. 01Revenue from Operations₹2,642 Cr
    2. 02Business EBITDA₹247 Cr
    3. 03Reported EBITDA₹266 Cr+60%YoY
    4. 04EPS₹12.3
    5. 05Return on Capital Employed22.7%

    Segment breakdown

    Legacy Sudarshan
    12% Sales Growth
    Acquired Group
    5% Revenue Growth₹65 Cr Business EBITDA (Q1 FY26)₹128 Cr Business EBITDA (Q1 FY27)₹78 Cr Reported EBITDA (Q1 FY26)₹146 Cr Reported EBITDA (Q1 FY27)
    RIECO Business
    ₹38 Cr Revenue from Operationsdrop EBITDA Impact
    One Sudarshan (Pigment Business)
    ₹275 Cr EBITDA
    List

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Debt

    Net ₹531 crores · 0.2x EBITDA

    Guidance & targets

    4
    CategoryTargetPriority
    Revenue
    Acquired Group Turnover
    Eur 700 million
    		Medium
    Revenue
    Long-term Revenue
    Rs.12,000 Crores plus
    		Low
    Profitability
    Acquired Group EBITDA
    EUR 35 million
    		Medium
    Profitability
    Acquired Group Margin
    high single digits or low double digits
    		Medium

    What to watch in Q2 FY27

    5

    Quantification of employee restructuring charge

    By Q2 FY27
    CurrentNot yet quantified
    TargetClarity on financial impact

    Why it matters

    This charge could materially impact profitability and is currently an unknown factor for investors.

    By the end of Q2 I think we should have clarity on the quantification of this. As of now, we cannot provide anything more than that because the numbers are quite fluid, so by next quarter, we will be able to provide some more color.

    Risks & concerns

    4
    RiskSeverity

    Geopolitical situation (Middle East crisis)

    Led to energy cost spikes, raw material cost increases, and logistic cycle delays by two weeks, impacting operations and costs. — Management acknowledged

    medium

    Customer purchasing delays

    Customers are delaying purchases and avoiding stock buildup due to market uncertainties, affecting sales volumes. — Management acknowledged

    medium

    RIECO business execution challenges

    Delays in customer readiness and subcontracting manpower availability led to revenue reduction and an EBITDA drop in the RIECO segment. — Management acknowledged

    medium

    Employee restructuring program financial impact

    An agreement for employee restructuring has been signed, but the financial impact is not yet quantified, posing an unknown cost for future quarters. — Management acknowledged

    medium

    Q&A highlights

    8

    “I would say that the inference that the volume as a decline may not be very accurate given a very broad spectrum of our product range. We sell our product range from €1 to €130 to €140, we are not able to kind of set that aside; however, given that we have seen a modest growth of 6% this quarter in spite of the geopolitical situation.”

    Analyst questioned the underlying volume performance, suggesting a decline despite reported growth, which management partially clarified by citing product range and geopolitical situation.

    asked by Sanjesh Jain

    2 min read6 chapters

    Detailed Narrative

    01

    Q1 FY27 Performance Overview

    Sudarshan Chemical Industries Limited reported a robust Q1 FY27 with revenue from operations at Rs.2642 Crores. The business EBITDA stood at Rs.247 Crores, while the reported EBITDA reached Rs.266 Crores, marking over 60% year-on-year growth. Earnings per share for the quarter was Rs.12.3, and the return on capital employed was a strong 22.7%.

    02

    Integration of Acquired Business and Value Capture

    The company highlighted the successful integration of its acquired business, which merged with Clariant and Heubach over 18 months ago. This integration has led to significant value creation, with management emphasizing that future profitability will largely stem from cost reduction and value capture initiatives. The acquired group itself grew revenue by 5% and business EBITDA from Rs.65 Crores to Rs.128 Crores in Q1 FY27.

    03

    Debt Reduction and Financial Health

    Sudarshan Chemical has significantly improved its financial health, reducing net debt by 60% from its peak of Rs.922 Crores to Rs.531 Crores in less than 18 months. This has resulted in a healthy debt-to-equity ratio of 0.2 and an annualized net working capital of 23.6%, positioning the company strongly for future growth and accelerated debt repayment.

    04

    Market Conditions and Geopolitical Impact

    The company acknowledged facing challenges due to the Middle East crisis, which led to energy cost spikes and increased raw material and logistic costs, extending the logistic cycle by two weeks. These geopolitical uncertainties also caused customers to delay purchases, impacting volumes. The RIECO business specifically faced execution challenges, resulting in a revenue of Rs.38 Crores and an EBITDA drop.

    05

    Outlook and FY27 Guidance

    For FY27, the company maintains its guidance for the acquired group, targeting a turnover of Eur 700 million and an EBITDA of Eur 35 million. Despite a stronger-than-expected Q1, management is not revising the guidance yet, opting for a 'wait and watch' approach given the geopolitical situation, with a reconsideration planned after Q2. Long-term, the company aspires to reach revenues of Rs.12,000 Crores plus.

    06

    Strategic Initiatives and SAP Integration

    Sudarshan is focused on strategic initiatives including setting up a global capability center in Pune and implementing an advanced 'One SAP' project (Project Integra) to streamline operations and reduce complexities, expected to go live within the current financial year. The company also noted that its gross profit margins are expected to remain in the 50% plus range, driven by cost reduction in yields, utilities, and production.

    This is an AI-generated summary of a publicly available earnings call transcript.